Cargando…
Drug-drug interactions in pharmaceutical development /
Drug-Drug Interactions in Pharmaceutical Development comprehensively reviews the relevant science, industrial practice, and regulatory agency positions on drug-drug interactions. It focuses on the evaluation of potential drug-drug interactions, allowing researchers to address risk factors before a d...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Hoboken, N.J. :
Wiley-interscience,
©2008.
|
| Colección: | Wiley series in drug discovery and development.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ma 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn608623827 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 070415s2008 njuaf ob 001 0 eng d | ||
| 010 | |z 2007015878 | ||
| 040 | |a MERUC |b eng |e pn |c MERUC |d E7B |d OCLCQ |d N$T |d YDXCP |d IDEBK |d OCLCQ |d DG1 |d TMY |d CUY |d OCLCQ |d OCLCO |d OCLCF |d OCLCQ |d NLGGC |d EBLCP |d MHW |d UKDOC |d OCLCQ |d COO |d OCLCQ |d D6H |d AZK |d LOA |d OCLCO |d JBG |d OCLCO |d OCLCA |d IAS |d OCLCO |d OCLCQ |d OCLCO |d TOA |d OCLCO |d AGLDB |d DG1 |d COCUF |d CHVBK |d OCLCO |d OCLCQ |d MOR |d LIP |d OCLCO |d PIFAG |d ZCU |d OCLCO |d OCLCQ |d MERUC |d OCLCQ |d U3W |d OCLCQ |d STF |d WRM |d VNS |d VTS |d INT |d REC |d OCLCA |d VT2 |d TOF |d AU@ |d OCLCO |d OCLCQ |d OCLCO |d WYU |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d DKC |d OCLCO |d OCLCQ |d M8D |d OCLCO |d OCLCQ |d OCLCA |d VLY |d AJS |d REDDC |d OCLCO |d OCL |d OCLCA |d OCLCQ |d OCLCO |d OCLCL | ||
| 019 | |a 181350025 |a 317117902 |a 476269799 |a 647763234 |a 698126972 |a 743432455 |a 746575858 |a 961543895 |a 962683834 |a 966249218 |a 974456796 |a 974509836 |a 988427224 |a 991916722 |a 1018028818 |a 1037912193 |a 1038574531 |a 1043489007 |a 1045531245 |a 1097130046 |a 1162238928 |a 1241884098 |a 1257349293 |a 1290071770 |a 1300465509 | ||
| 020 | |a 9780470187913 |q (electronic bk.) | ||
| 020 | |a 0470187913 |q (electronic bk.) | ||
| 020 | |a 9780470187920 | ||
| 020 | |a 0470187921 | ||
| 020 | |z 9780471794417 |q (cloth) | ||
| 020 | |z 0471794414 |q (cloth) | ||
| 020 | |a 1282022067 | ||
| 020 | |a 9781282022065 | ||
| 020 | |a 9786612022067 | ||
| 020 | |a 661202206X | ||
| 024 | 7 | |a 10.1002/9780470187920 |2 doi | |
| 029 | 1 | |a AU@ |b 000043398316 | |
| 029 | 1 | |a AU@ |b 000051544877 | |
| 029 | 1 | |a CHNEW |b 000935367 | |
| 029 | 1 | |a CHVBK |b 480157111 | |
| 029 | 1 | |a DEBBG |b BV043146671 | |
| 029 | 1 | |a DEBBG |b BV043391197 | |
| 029 | 1 | |a DEBBG |b BV044134602 | |
| 029 | 1 | |a DEBSZ |b 422015709 | |
| 029 | 1 | |a DEBSZ |b 484983059 | |
| 029 | 1 | |a NZ1 |b 13340219 | |
| 035 | |a (OCoLC)608623827 |z (OCoLC)181350025 |z (OCoLC)317117902 |z (OCoLC)476269799 |z (OCoLC)647763234 |z (OCoLC)698126972 |z (OCoLC)743432455 |z (OCoLC)746575858 |z (OCoLC)961543895 |z (OCoLC)962683834 |z (OCoLC)966249218 |z (OCoLC)974456796 |z (OCoLC)974509836 |z (OCoLC)988427224 |z (OCoLC)991916722 |z (OCoLC)1018028818 |z (OCoLC)1037912193 |z (OCoLC)1038574531 |z (OCoLC)1043489007 |z (OCoLC)1045531245 |z (OCoLC)1097130046 |z (OCoLC)1162238928 |z (OCoLC)1241884098 |z (OCoLC)1257349293 |z (OCoLC)1290071770 |z (OCoLC)1300465509 | ||
| 037 | |a 10.1002/9780470187920 |b Wiley InterScience |n http://www3.interscience.wiley.com | ||
| 050 | 4 | |a RM302 |b .D755 2008eb | |
| 060 | 4 | |a 2007 M-292 | |
| 060 | 4 | |a QV 38 |b D7916 2008 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 0 | 4 | |a 615/.7045 |2 22 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Drug-drug interactions in pharmaceutical development / |c edited by Albert P. Li. |
| 260 | |a Hoboken, N.J. : |b Wiley-interscience, |c ©2008. | ||
| 300 | |a 1 online resource (xiv, 244 pages, [1] pages) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file |2 rda | ||
| 490 | 1 | |a Wiley series in drug discovery and development | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a In vitro evaluation of metabolic drug-drug interactions: concepts and practice / Albert P. Li -- In vitro approaches to anticipating clinical drug interactions / Laurie P. Volak, David J. Greenblatt, Lisa L. von Moltke -- Inhibition of drug metabolizing enzymes and drug-drug interactions in drug discovery and development / R. Scott Obach -- Mechanism-based CYP inhibition: enzyme kinetics, assays, and prediction of human drug-drug interactions / Magang Shou -- Genomic approaches to drug-drug interactions / Yi Yang, Jeffrey F. Waring -- Transporters and drug interactions / Yoshihisa Shitara, Toshiharu Horie, and Yuichi Sugiyama -- Transporter-mediated drug interactions: molecular mechanisms and clinical implications / Jiunn H. Lin -- Recent case studies of clinically significant drug-drug interactions and the limits of in vitro prediction methodology / R.H. Levy, I. Ragueneau-Majlessi, C. Collins -- US regulatory perspective: drug-drug interactions / John Strong and Shiew-Mei Huang -- Herbal drug interactions: a Canadian perspective / Brian C. Foster. | |
| 588 | 0 | |a Print version record. | |
| 520 | |a Drug-Drug Interactions in Pharmaceutical Development comprehensively reviews the relevant science, industrial practice, and regulatory agency positions on drug-drug interactions. It focuses on the evaluation of potential drug-drug interactions, allowing researchers to address risk factors before a drug is put to market. The book covers both clinical and nonclinical aspects for understanding drug-drug interactions as well as in vitro and in vivo studies for use in studying interactions at the drug discovery stage. | ||
| 546 | |a English. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Drug interactions. | |
| 650 | 0 | |a Drug development. | |
| 650 | 0 | |a Pharmaceutical chemistry. | |
| 650 | 1 | 2 | |a Drug Interactions |
| 650 | 2 | 2 | |a Chemistry, Pharmaceutical |
| 650 | 2 | |a Drug Combinations | |
| 650 | 6 | |a Interactions médicamenteuses. | |
| 650 | 6 | |a Médicaments |x Développement. | |
| 650 | 6 | |a Chimie pharmaceutique. | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Pharmaceutical chemistry |2 fast | |
| 650 | 7 | |a Drug development |2 fast | |
| 650 | 7 | |a Drug interactions |2 fast | |
| 650 | 7 | |a Arzneimittelentwicklung |2 gnd | |
| 650 | 7 | |a Arzneimittelwechselwirkung |2 gnd | |
| 700 | 1 | |a Li, A. P. | |
| 758 | |i has work: |a Drug-drug interactions in pharmaceutical development (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGrFdYXFQd89gjTkH4Gv9C |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Drug-drug interactions in pharmaceutical development. |d Hoboken, N.J. : Wiley-interscience, ©2008 |w (DLC) 2007015878 |
| 830 | 0 | |a Wiley series in drug discovery and development. | |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=427662 |z Texto completo |
| 938 | |a 123Library |b 123L |n 4493 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL427662 | ||
| 938 | |a ebrary |b EBRY |n ebr10296311 | ||
| 938 | |a EBSCOhost |b EBSC |n 267551 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 202206 | ||
| 938 | |a YBP Library Services |b YANK |n 2940024 | ||
| 938 | |a YBP Library Services |b YANK |n 2989119 | ||
| 994 | |a 92 |b IZTAP | ||